Super-potent morphine sulfate recalled

FDA announced on Tuesday that Pharmakon Pharmaceuticals is voluntarily recalling morphine sulfate 0.5 mg/mL preservative free in 0.9% sodium chloride. The product comes in a 1 mL syringe, CII, for I.V. use. The recall was initiated after the drug company received lab results indicating the product was “super potent.” FDA said it was informed on February 16 of serious adverse events in three infants associated with the use of the recalled product. Administering super-potent morphine to a patient could result in respiratory depression, coma, and even death.